Neuro-Oncology Practice is a leading journal in the interdisciplinary field of neuro-oncology, published by Oxford University Press. With an ISSN of 2054-2577 and E-ISSN 2054-2585, this journal provides a critical platform for the dissemination of cutting-edge research and clinical advancements since its inception in 2014. As of 2023, it has achieved a Q2 ranking in Medicine (Miscellaneous), Neurology, and Oncology categories, reflecting its esteemed position in the academic community with impressive Scopus rankings, including a 74th percentile in the field of Medicine. Despite its non-open access status, Neuro-Oncology Practice aims to bridge the gap between laboratory research and clinical practice, offering valuable insights for professionals involved in the treatment and study of neurological cancers. The journal actively encourages submissions that explore innovative treatment strategies, enhance patient care, and advance our understanding of the complexities surrounding brain tumors. With a convergence period extending to 2024, it remains a crucial resource for researchers, practitioners, and students who are committed to improving outcomes in the field of neuro-oncology.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

Journal of Cancer Policy is an esteemed publication devoted to the critical intersection of health policy and oncology. Published by Elsevier Sci Ltd in the United Kingdom, this journal has been a pivotal platform since its inception in 2013, contributing to the field's discourse on cancer management and policy-making strategies. With an impressive Q2 ranking in both the Health Policy and Oncology categories for 2023, it underscores its significance in shaping policy frameworks that address the complexities of cancer care. The journal is listed in Scopus with a respectable rank of #177 in Health Policy and #261 in Oncology, indicating its broad reach and impactful contributions to research and scholarly discussions. While the journal operates under a subscription model, it aims to provide readers with high-quality research that can influence health decisions and policy formation. As a vital resource for researchers, healthcare professionals, and students alike, the Journal of Cancer Policy plays a fundamental role in advancing the understanding of how policies can improve cancer outcomes and healthcare systems.

Medecine Palliative is a distinguished journal published by Elsevier, dedicated to the vital field of palliative care and pain management. With an ISSN of 1636-6522 and E-ISSN 2213-0098, this international journal has been an essential resource since its inception in 1970, currently covering research from 2004 to 2024. The journal reflects a commitment to enhancing the quality of life for patients facing serious illnesses, addressing critical issues in Anesthesiology and Oncology, while fostering innovative nursing practices in palliative care. While the journal holds a Q3 ranking in Anesthesiology and Pain Medicine and a Q4 in Oncology categories, making it a valuable venue for researchers and practitioners aiming to contribute to the evolving landscape of palliative medicine. Despite its lower rank in some categories, the journal serves as an important platform for insights, clinical findings, and current practices that can significantly impact patient care. Medecine Palliative is accessible to researchers, professionals, and students who are eager to explore the latest advancements and evidence-based approaches in end-of-life care.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.

International Journal of Palliative Nursing is a renowned peer-reviewed journal dedicated to advancing the field of palliative care and nursing. Published by MA HEALTHCARE LTD in the United Kingdom, this journal has been a pivotal resource for healthcare professionals, researchers, and students alike since its inception in 2000. With an ISSN of 1357-6321, it is well-regarded for its commitment to high-quality research and practical insights, maintaining a Q3 category ranking in Advanced and Specialized Nursing. Despite its non-open access format, the journal offers a wealth of knowledge through a diverse array of articles that cover the latest advancements and best practices in palliative nursing. Its Scopus Rank at #36/63 reflects its respectable standing in the nursing community and highlights its contributions to the interdisciplinary realm of palliative care. The journal is an invaluable platform for fostering dialogue and sharing innovative approaches to nurture compassionate patient care.

Indian Journal of Palliative Care is a premier peer-reviewed publication dedicated to advancing the field of palliative care within the broader domains of health policy and public health. Published by SCIENTIFIC SCHOLAR LLC in India since 2003, this Open Access journal is committed to providing a platform for innovative research and practices that promote quality of life for patients with life-limiting illnesses. With a focus on health policy and environmental and occupational health, the journal holds a respected position in the Q3 quartile for both categories, reflecting its significant contributions to scholarly discourse. Ranked #393 in Public Health and #185 in Health Policy according to Scopus, it serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding of palliative care and its implications within public policy and health frameworks. Through its rigorous editorial standards and broad accessibility, the Indian Journal of Palliative Care plays a vital role in shaping effective solutions and policies that aim to enhance patient care and well-being.

Medycyna Paliatywna-Palliative Medicine is a vital academic journal dedicated to advancing the field of palliative care, published by TERMEDIA PUBLISHING HOUSE LTD. With its ISSN 2081-0016 and E-ISSN 2081-2833, this journal serves as a reputable source of high-quality research and compelling insights for scholars, healthcare professionals, and students committed to improving the quality of life for patients with serious illnesses. Although it does not currently offer Open Access, Medycyna Paliatywna ensures that articles published within its pages undergo rigorous peer review, reflecting the highest standards in medical research. The journal aims to contribute to the ongoing dialogue in palliative medicine, encouraging innovative practices, sharing evidence-based strategies, and fostering collaboration among healthcare providers. By disseminating important findings and clinical insights, Medycyna Paliatywna plays a crucial role in shaping the future direction of palliative care, making it an essential resource for anyone involved in this critical field.